The 'rule of halves' still applies to the management of cholesterol in cardiovascular disease: 2002-2005

British Journal of Cardiology

Volumn 13, Issue 2, 2006, Pages 145-153

  de Lusignan, Simon ^a   Hague, Nigel ^a   Belsey, Jonathan ^a   Dhoul, Neil ^a   van Vlymen, Jeremy ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Audit; Cardiovascular disease; Cholesterol; Computerised; Coronary heart disease; Medical record; Primary care; Secondary prevention

Indexed keywords

CHOLESTEROL;

ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; ELECTRONIC MEDICAL RECORD; GENERAL PRACTICE; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL AUDIT; PATIENT CARE; PREVALENCE; PRIMARY MEDICAL CARE; SECONDARY PREVENTION; UNITED KINGDOM;

EID: 33646190037     PISSN: 09696113     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Kannel WB, Dawber TR, Kagan A et al. Factors of risk in the development of coronary heart disease - six year follow-up experience; the Framingham Study. Ann Intern Med 1961;55:33-50.
2. Shaper AG, Pocock SJ, Walker M et al. Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J Epidemiol Commun Health 1985;39:197-209.
3. Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor intervention Trial (MRFIT). JAMA 1986;256:2823-8.
4. Leitch D. Who should have their cholesterol concentration measured? What experts in the United Kingdom suggest. BMJ 1989;298: 1615-16.
5. Anggard EE, Land JM, Lenihan CJ et al. Prevention of cardiovascular disease in general practice: a proposed model. BMJ 1986; 293:177-80.
6. Vivier PM, Dietrich AJ, Witters LA. Management of elevated cholesterol levels by New Hampshire primary care physicians. J Fam Pract 1988;27:167-72.
7. Wood D, DeBacker G, Faegerman O et al. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the second joint task force of European and other societies on coronary heart prevention. Eur Heart J 1998;80:1-10.
8. Department of Health. National Service Framework for Coronary Heart Disease. London: Department of Health, 2000.
9. Williams B, Poulter N, Brown M et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004 - BHS IV. J Hum Hypertens 2004;18:139-85.
10. British Cardiac Society; British Hypertension Society; Diabetes UK; HEART UK; Primary Care Cardiovascular Society; Stroke Association. JBS2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005;91(suppl 5):v1-52.
11. NICE (National Institute for Health and Clinical Excellence). Use of statins in primary prevention of CVD. URL: http://www.nice.org.uk/page.aspx?o=289665.
12. Department of Health. Primary Care Contracting - Quality and Outcomes Framework (QOF). http://www.dh.gov.uk/PolicyAndGuidance/OrganisationPolicy/PrimaryCare/ PrimaryCareContracting/fs/en
13. Capuano V, Bambacaro A, D'Arminio T et al. Changes in total serum cholesterol for cardiovascular disease in a Mediterranean area, 1989-1999. Eur J Epidemiol 2003;18:27-32.
14. Anderssen SA, Hjelstuen AK, Hjermann I et al. Fluvastatin and lifestyle modification for reduction of carotid intima-media thickness and left ventricular mass progression in drug-treated hypertensives. Atherosclerosis 2005;178:387-97.
15. Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health Med 2003;25:144-53.
16. Kang S, Wu Y, Li X. Effects of statin therapy on the progression of carotid atherosclerosis: a systematic review and meta-analysis. Atherosclerosis 2004;177:433-42.
17. Amarenco P, Labreuche J, Lavallee P et al. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 2004;35:2902-09.
18. de Lusignan S, Hague N, Yates C et al. A case study from a Sussex Primary Care Group: improving secondary prevention in coronary heart disease using an educational intervention. Br J Cardiol 2002; 9:362-8.
19. de Lusignan S, Dzregah B, Hague N et al. Cholesterol management in patients with ischaemic heart disease: an audit-based appraisal of progress towards clinical targets in primary care. Br J Cardiol 2003; 10:223-8.
20. de Lusignan S, Hague N, Brown A et al. An educational intervention to improve data recording in the management of ischaemic heart disease in primary care. J Public Health (Oxf) 2004;26:34-7.
21. de Lusignan S. Using the feedback of routinely collected computer data to improve the quality of chronic disease management in UK primary care. Acta Informatica Medica 2005;13:59-63.
22. Primary Care Data Quality programme. What is MIQUEST? http://www.pcdq.org/miquest.htm
23. van Vlymen J, de Lusignan S, Hague N, Chan T, Dzregah B. Ensuring the quality of aggregated general practice data: lessons from the Primary Care Data Quality Programme (PCDQ). Stud Health Tech Infor 2005;116: 1010-15.
24. Stroes E. Statins and LDL-cholesterol lowering: an overview. Curr Med Res Opin 2005;21(suppl 6):S9-S16.
25. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet 2002;360:7-22.
26. Edwards JE, Moore RA. Statins in hypercholesterolaemia: a dose-specific meta-analysis of lipid changes in randomised, double blind trials. BMC Fam Pract 2003;4:18-37.
27. The LIPID Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1995;339:1349-57.
28. LaRosa JC, Grundy SM, Waters DD et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005;352:1425-35.
29. Guyton JR, Blazing MA, Hagar J et al. Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group. Arch Intern Med 2000;160: 1177-84.
30. Kastelein JJ, Sager PT, de Groot E et al. Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hypercholesterolemia. Design and rationale of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial. Am Heart J 2005;149:234-9.
31. Brown G. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001; 345:1583-92.
32. Mantel-Teeuwisse AK, Klungel OH, Schalekamp T et al. Suboptimal choices and dosing of statins at start of therapy. Br J Clin Pharmacol 2005;60:83-9.
33. Bazalo GR. Managed care trends in statin usage. Manag Care 2001;10:48-59.
34. Pitt B. Low-density lipoprotein cholesterol in patients with stable coronary heart disease - is it time to shift our goals? N Engl J Med 2005;352:1483-4.
35. Toal M, Walker R. Angiotensin converting enzyme (ACE) inhibitors in the treatment of heart failure in general practice in north Cumbria. Eur J Heart Fail 2000;2:201-07.
36. Porcu M, Opasich C, Scherillo M et al. Improving practice patterns in heart failure through a national cardiological network: the case of ACE-inhibitors. Ital Heart J 2002;3: 730-7.
37. Thiru K, de Lusignan S, Sullivan F et al. Three steps to data quality. Inform Prim Care 2003; 11:95-102.
38. Thiru K, Hassey A, Sullivan F. Systematic review of scope and quality of electronic patient record data in primary care. BMJ 2003;326:1070-5.
39. Gray J, Majeed A, Kerry S et al. Identifying patients with ischaemic heart disease in general practice: cross sectional study of paper and computerised medical records. BMJ 2000;321:548-50.
40. Department of Health. Prevalence recorded for diseases in the new GMS contract for 2004/5. http://www.gponline.com/attachments/pdfs/UKprevalence.pdf (Accessed 17/6 /2005).